PIPELINE
RevolKaは、aiProtein®固有の適応範囲の広さを活かし、様々な疾患に対する治療薬開発及び各種領域の新規タンパク質の開発を行っています。
Project | Modality | Area | Development Stage | Partner |
RKD001 | Protein | Therapeutics (Rare Disease) |
Lead Discovery | |
RKD002 | Protein | Therapeutics (Rare Disease) |
Lead Discovery | |
RK001 | Antibody | Therapeutics (Immunooncotherapy) |
Technology development | |
RK002 | Antibody | Therapeutics (Oncology) |
Technology development | |
RK003 | Protein | Therapeutics (Rare Disease) |
Undisclosed | |
RK004 | Protein | Undisclosed | Undisclosed | |
RK006 | Coming soon | |||
RK007 | Coming soon | |||
RK008 | Coming soon | |||
RK009 | Protein | Vaccines (Infectious diseases) |
Research collaboration |